BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15846652)

  • 1. Emergency interventions for hyperkalaemia.
    Mahoney BA; Smith WA; Lo DS; Tsoi K; Tonelli M; Clase CM
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003235. PubMed ID: 15846652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD005257. PubMed ID: 22592703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for the acute management of hyperkalaemia in adults.
    Batterink J; Cessford TA; Taylor RA
    Cochrane Database Syst Rev; 2015 Oct; 10(10):CD010344. PubMed ID: 35658162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
    Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of hyperkalaemia in the emergency department.
    Ahee P; Crowe AV
    J Accid Emerg Med; 2000 May; 17(3):188-91. PubMed ID: 10819381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hyperkalaemia.
    Maxwell AP; Linden K; O'Donnell S; Hamilton PK; McVeigh GE
    J R Coll Physicians Edinb; 2013; 43(3):246-51. PubMed ID: 24087806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA).
    Montassier E; Lemoine L; Hardouin JB; Rossignol P; Legrand M
    BMJ Open; 2020 Aug; 10(8):e039277. PubMed ID: 32847923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant.
    Mildenberger E; Versmold HT
    Eur J Pediatr; 2002 Aug; 161(8):415-22. PubMed ID: 12172823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
    Brand A; Visser ME; Schoonees A; Naude CE
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015207. PubMed ID: 35944931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
    Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled magnesium sulfate in the treatment of acute asthma.
    Knightly R; Milan SJ; Hughes R; Knopp-Sihota JA; Rowe BH; Normansell R; Powell C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003898. PubMed ID: 29182799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol for hyperkalaemia in children.
    Helfrich E; de Vries TW; van Roon EN
    Acta Paediatr; 2001 Nov; 90(11):1213-6. PubMed ID: 11808886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
    Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
    Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.